Aptorum Group Limited (Nasdaq: APM)

At Aptorum, we believe that by facilitating the development of medical innovations, particularly in those that able to meet current unmet medical needs and significantly improve clinical and surgical experience, is inevitable in advancing the quality of human life and patient care. With this vision, Mr. Ian Huen founded Aptorum, leveraging talented specialists and prosperous medical resources across the globe, to accelerate the evolution of potentially First-in-Class/Best-in-Class therapeutic and diagnostic innovations across a wide range of disease areas. By combining a broad pipeline of early stage novel medical innovations and multi-disciplinary human capital, Aptorum aims to become a world class...

Biotechnology,pharmaceutical,lifescience,and therapeutics

Aptorum group limited (nasdaq: apm) operates in the Biotechnology research industry.

Aptorum group limited (nasdaq: apm)'s revenue is < 1m

Aptorum group limited (nasdaq: apm) has 11 - 50 employees.